Berlin-based period-tracking company Clue has launched Get Care, a new initiative connecting users with specialist healthcare providers across contraception, fertility, diagnostics, metabolic health and mental health.
The free service, launched on 8 October in the UK, US and Germany, allows users to discover healthcare providers through the Clue app, with perimenopause and menopause care due to follow in November.
The move aims to address the gap between women using digital tools to understand their health and accessing appropriate healthcare services.
In a survey of almost 12,000 Clue users, two-thirds reported concerns about their menstrual health, with most managing symptoms independently. Nearly one in four new users said gathering information to share with a healthcare professional was an important reason for joining the app.
“Women are already using their Clue data to navigate the healthcare system and advocate for the care they need,” said Rhiannon White, chief executive of Clue.
“But women should not have to do all the work of connecting what they know about their bodies with the care available to them.”
Get Care brings together a network of specialist providers, including TwentyEight Health, Evaro, TeleClinic and inne for contraception; Plan Your Baby for fertility and conception; Hertility for hormone and fertility testing; Embla for weight and metabolic health; and Navicare for mental health support.
Evaro is expected to add weight management and perimenopause and menopause care to the platform in November.
Clue is also working with pharmaceutical company Novo Nordisk to improve access to information and professional advice on women’s metabolic health, including during perimenopause.
The collaboration brings metabolic health into a platform traditionally associated with menstrual and reproductive health, reflecting growing recognition of the connections between reproductive, hormonal and metabolic conditions.
Expanding beyond period tracking
The launch marks a further expansion of Clue’s role beyond cycle tracking, as the company looks to connect its existing audience with a wider range of healthcare services.
Clue reports that more than 100 million people across 190 countries have used its app since launch.
The initiative could also create a new route to patients for specialist women’s health companies, many of which face significant challenges in customer acquisition and reaching women who could benefit from their services.
Clue says providers joining Get Care are vetted against criteria covering scientific evidence, regulatory clearance where required, and accessibility.
The launch builds on Clue’s wider ecosystem of partnerships and integrations, including with wearable technology providers Oura, Apple Watch, Garmin, WHOOP and Withings.
Further healthcare partners, services and international markets are planned.